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Self-tracking of Physical Activity in People With
Type 2 Diabetes
A Randomized Controlled Trial
Thea J.M. Kooiman, MSc, Martijn de Groot, PhD, Klaas Hoogenberg, MD, PhD, Wim P. Krijnen, PhD,
Cees P. van der Schans, PhD, PT, CE, Adriaan Kooy, MD, PhD
Thepurposeof this studywas to determine theefficacy of anon-
line self-tracking program on physical activity, glycated hemoglo-
bin, and other healthmeasures in patients with type 2 diabetes.
Seventy-two patients with type 2 diabetes were randomly
assigned to an intervention or control group. All participants
received usual care. The intervention group received an activity
tracker (Fitbit Zip) connected to an online lifestyle program.
Physical activity was analyzed in average steps per day from
week 0 until 12. Health outcome measurements occurred
in both groups at baseline and after 13 weeks. Results indi-
cated that the intervention group significantly increased
physical activity with 1.5 ± 3 days per week of engagement
in 30 minutes of moderate-vigorous physical activity versus
no increase in the control group (P = .047). Intervention par-
ticipants increased activity with 1255 ± 1500 steps per day
compared to their baseline (P < .010). No significant differ-
ences were found in glycated hemoglobin A1c, with the inter-
vention group decreasing −0.28% ± 1.03% and the control
group showing −0.0% ± 0.69% (P = .206). Responders
(56%, increasing minimally 1000 steps/d) had significantly
decreased glycated hemoglobin compared with nonre-
sponders (−0.69%±1.18% vs0.22%±0.47%, respectively;
P = .007). To improve effectiveness of eHealth programs,
additional strategies are needed.
KEY WORDS: eHealth intervention, Physical activity,
Self-management, Type 2 diabetes, Wearable technology
M ore than 400 million people worldwide have diabe-tes, with an increased risk of cardiovascular disease,cancer, and dementia.1 Physical inactivity and be-
ing overweight due to an unhealthy lifestyle are key factors
in both the onset and progression of type 2 diabetes.2,3 In-
creasing physical activity and adopting a healthy lifestyle
are essential for preventing long-term complications and
comorbidity, as these improve glycemic control (measured
by glycated hemoglobin A1c levels [HbA1c]) and reduce
weight.3–6 Therefore, stimulating physical activity is of great
importance within daily clinical practice for people with
type 2 diabetes, especially for nursing care. Physical activity
guidelines for this population recommend engagement in
progressive, moderate to vigorous resistance training, in ad-
dition to a minimum of 150 minutes of moderate to vigorous
physical activity (MVPA) per week and avoidance of pro-
longed sedentary activities.6,7 Since walking is generally an
appropriate activity for those with diabetes, these recom-
mendations can be translated into taking at least 7500 steps
per day (steps/d), of which 3000 steps should be at amoderate
to vigorous intensity.8 A recent report suggests that beginning
with 10 minutes of MVPA per day (1000 steps/d) would be a
feasible start toward achieving these guidelines for sedentary
individuals in midlife.9
Many people worldwide, including people with type 2 dia-
betes, do not comply with physical activity guidelines.3 More-
over, people who are overweight tend to overestimate their
level of physical activity compared with people who have a
healthy weight.10 Adherence to physical activity recommen-
dations from healthcare professionals is low in people with
diabetes,11 or may not have sustainable effects on physical
activity behavior and glycemic control. A large trial of an
intensive lifestyle program found significant improvements
in health outcomes after 1 year of follow-up. However, these
effects diminished after 10 years of follow-up.12 Factors that
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influence the absence of long-term adherence to exercise ad-
vice can vary; for example, low levels of health literacy, lack of
motivation, negative beliefs about physical activity, inconve-
nience of being active, lack of time, lack of an adequate exercise
plan, and overly vigorous intensification leading to injuries.11,13
Several behavioral intervention components have been
identified as crucial for facilitating incremental physical
activity, including those for individuals with type 2 diabetes.
According to Social Cognitive Theory, certain beliefs about
the desired behavior and oneself are needed to accomplish
behavioral change. These beliefs include a positive attitude
about the desired behavior, positive outcome expectations,
and adequate self-efficacy beliefs for performance of the
behavior. The latter plays a significant role because self-
efficacy beliefs directly affect behavior and the goals that
people set for themselves.14,15 Positive beliefs about physical
activity and self-efficacy for exercise can be influenced by
education, tailoring of health information, use of a trusted
source, and a gradual intensification of activity aimed at
small goals.14,15 In addition, setting goals is an important
component of many interventions, because goals motivate
individuals to decrease discrepancy between the current
and desired states.16 Goals should be both behavioral (eg, in-
crease steps per day) and outcome related (eg, weight loss).16–18
After an individual has made adjustments in behavior, positive
feedback on this new behavior is very important for maintain-
ing motivation. Self-monitoring of behavior is recognized as
an essential strategy to gain personalized feedback and to
stimulate positive learning experiences.15,17,19 These strat-
egies are part of a well-known taxonomy of behavioral change
techniques (BCTs).17,18 These BCTs enable intervention de-
signers to use an evidence-based, reproducible, and uniform
intervention description.
Electronic health systems, such as mobile health tech-
nology, are increasingly used in the treatment for people
with type 2 diabetes, in order to optimize diabetes self-
management behaviors.20 These systems make it possible
to design interventions that include evidence-based strate-
gies to improve physical activity and glycemic control in
people with diabetes.20–22 In the past several years, differ-
ent activity monitoring devices have been developed.23
Modern consumer-level activity trackers can increase
awareness about an individual's actual physical activity
and facilitate goal setting and personalized feedback.17,18,23
Previous studies have shown that early versions of activity
monitors, such as simple pedometers, can encourage an
increase in physical activity in people with diabetes.24,25
However, there is a gap between the introduction of these
newly developed consumer level technologies and the evi-
dence for the effectiveness of their use in clinical care.26 In
addition, stimulation of physical activity within nursing
care is not yet considered to be “usual care” and requires
further exploration.27,28 Therefore, we designed an online
behavioral intervention program that was connected to a
modern consumer-level activity tracker. The purpose of
this program was to assist individuals with type 2 diabetes
to establish a healthy lifestyle.
Study Purpose
The purpose of this randomized controlled trial (RCT) was
to evaluate this online self-tracking program for physical
activity, glycemic control (measuring HbA1c) and other
health outcome measures (advanced glycation end product
[AGE], weight, body mass index [BMI], waist-hip ratio,
and self-reported health) in patients with type 2 diabetes.
We hypothesized that the online self-tracking program would
positively affect physical activity, HbA1c, and other health
outcome measures in the intervention group compared to
the control group. In addition, we hypothesized that, within
the intervention group, participants who increased physical
activity with a minimum of 1000 steps/d would demonstrate
a greater reduction in HbA1c compared with participants
who increased physical activity with fewer than 1000 steps/d.
METHODS
Study Design
This study was designed as an RCT. In addition to usual
care, the intervention group received an activity tracker con-
nected to an online program that was meant to encourage
them to initiate a healthy lifestyle. The control group re-
ceived only usual care, that is, visits every 3 months with a
diabetes nurse and/or an internist for monitoring HbA1c and
advice regarding medication, lifestyle, and weight reduction
in order to normalize blood glucose levels.29 No restrictions
were specified regarding the prescription of additional med-
ication before or within the study period. The study had a
total duration of 13 weeks (baseline week 0 and interven-
tion weeks 1–12). Primary and secondary outcome mea-
sures were assessed at baseline (T0) and at the end of the
trial (T1). The research and intervention were conducted
by diabetes nurses (ie, nurses with additional training to
care for patients with diabetes) employed in two hospitals
in the Netherlands. The diabetes nurses received a study
protocol and training by the research team before the be-
ginning of the study. The study protocol described the en-
rollment, measurement, and intervention procedures in
detail. The research team provided support to the diabe-
tes nurses during the entire study period.
Participants
Eligible participants were patients with type 2 diabetes,
18 years of age or older, with HbA1c of 7.5% (58 mmol/mol)
or greater, access to the Internet, and the ability to use
a computer. Exclusion criteria were pregnancy, already
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engaging in more than 3 hours of intensive exercise per week,
or comorbidity or cognitive dysfunction interfering with phys-
ical activity. Participants received outpatient care and were
not hospitalized. All participants provided informed consent.
The complete study protocol was approved by the medical
ethics committee of the University Medical Center Groningen
(file number 2014-334) and was published in the Dutch Trial
Register (NTR5215).
Recruitment, Randomization, and Allocation
Participants were recruited at the Bethesda General Hos-
pital (Bethesda Diabetes Research Center, Hoogeveen, the
Netherlands) and the Martini Hospital (Groningen, the
Netherlands). Recruitment methods included flyers, let-
ters, and an advertisement in a local newspaper, and eligible
patients were invited by the diabetes nurse. After stratifica-
tion for HbA1c and BMI (based on the mean values of par-
ticipants included thus far), participants were randomly
assigned to the intervention or control group using block
randomization.30 A predetermined formula per block (eg,
ICCI) determined to which group a patient was assigned.
Figure 1 illustrates the flowchart of recruitment of the partic-
ipants in the study.
Intervention
The intervention group received usual care plus an activity
tracker (Fitbit Zip; Fitbit Inc, San Francisco, CA) and access
to the online self-tracking (eHealth) program. The activity
tracker was linked to the personal accounts of the partici-
pants in the eHealth program. The program was designed
by a project group composed of members from healthcare
organizations, health training institutes, and technology com-
panies. The complete content of the program aimed to optimize
knowledge about a healthy lifestyle, increase awareness of
individual physical activity, increase self-efficacy for exercise,
and ultimately optimize and maintain a healthy lifestyle. Im-
portant BCTs of the intervention were providing informa-
tion about health consequences; setting behavioral goals;
setting outcome goals; barrier identification/problem solv-
ing and action planning (through the eHealth program);
behavioral self-monitoring and review of behavioral goals
(through the Fitbit device); and providing feedback on be-
havior, habit formation, habit reversal, and graded tasks
(through both the Fitbit device and the eHealth program).14–18
In more detail, the participants were instructed to maintain
their usual activity pattern in week 0 to determine their baseline
activity level. Beginning in week 1, they were encouraged by
the diabetes nurse and the eHealth program to set incremental
activity goals, based on their individual baseline activity level
(ie, behavioral goals) and outcome goals (eg, losing weight).
Participants were encouraged to begin with small goals such
as increasing 500 or 1000 steps/d and, depending on their
individual capabilities, continuing to increase to the norm
of a minimum of 7500 steps/d or 150 minutes of MVPA
FIGURE 1. Flowchart of recruitment process for participants in the study.
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per week.6,8 The participants could easily contact the diabe-
tes nurse throughout the program for questions and support.
The program provided weekly information about physical
activity, a healthy diet with sample recipes appropriate for
those with diabetes, and videos of strength exercises with an
explanation of how to build muscle strength. The information
explained the benefits of healthy behavior and addressed fre-
quent barriers that people experience when engaging in phys-
ical activity.11,13 For example, to counteract a frequent barrier
“lack of time,” information and instructions on physical activ-
ity included several strategies to increase steps per day that
could be integrated even during the workday. In addition,
tailored feedback messages were provided through the pro-
gram once per week based on the number of steps taken in
the past week. These messages were based on whether the
participants had increased their steps per day with an average
minimum of 500 steps/d, stayed the same, or decreased their
steps per day compared to the previous week. All messages,
including in the event of a decrement in activity, had a positive
tone, provided fun facts, and were meant to encourage the
participant to increase activity levels.
Outcome Measures
Data collection was undertaken by the research nurse at T0
and T1. The self-reported behavioral measures were com-
pleted by the participants at T0 and T1 via digital question-
naires provided by the eHealth program.
Physical Activity
Physical activity was the intermediate outcome measure and
was measured with a 1-item physical activity questionnaire
that indicated howmany days per week a participant engaged
in 30 minutes of MVPA. This questionnaire has strong reli-
ability and good validity compared to expert classification of
subjects in the 30 minutes of MVPA recommendation.31 In
addition, within the intervention group, physical activity
was measured with the Fitbit Zip in steps/d. This activity
tracker could be clipped to the clothing or placed in a trouser
pocket. The Fitbit Zip has been shown to be reliable and
valid.32 Participants were asked to place the activity tracker
consistently in the preferred wearing position to optimize
validity and reliability of the data.32
Primary Outcome
The primary outcome was HbA1c (percentage and mil-
limoles per mole), as measured during usual care in
specialized laboratories.
Secondary Health Outcome Measures
Advanced glycation end products were measured in skin
fluorescence (SF; fluorescent properties of AGEs in the
skin) with the AGE Reader mu (Diagnoptics, Groningen,
the Netherlands), according to the device protocol. This
device has been shown to be reliable and valid.33,34
For weight (kilograms) or BMI (kilograms per square me-
ter), body weight was measured on a regular scale without
shoes or extra clothing and was translated to BMI using
the height of the participant. Height was measured in a
standing position without shoes using a measuring bar.
Waist-hip ratio in centimeters was calculated by dividing
the waist circumference by the hip circumference. Waist cir-
cumference was measured according to a protocol, with the
participant in a standing position, at the midpoint between
the lowest rib and the iliac crest.35
Subjective health score was measured on a visual analog
scale ranging from 0 to 10, with 10 indicating the best health
an individual could imagine and 0 indicating the worst. This
score has been shown to be reliable and valid.36
For changes in the use and dosage of medication, per
participant, all diabetes-related medications, including oral
medication (metformin, Sulfonylureas [SU], acarbose, and
Dipeptidyl peptidase-4 [DPP-4] inhibitor), Glucagon-like
peptide-1 (GLP-1) therapy, and units of insulin use per day,
were assessed at baseline and T1. An adjustment for changes
in HbA1c-influencing medication was needed to reliably
study the effects of the intervention on the primary endpoint
(HbA1c). Clinically relevant extra medication at T0 was defined
as a dose increase of 25% of oral medication, an increase of a
minimumof 4 units of insulin, or additional diabetesmedication.
A clinically relevant change in medication at T1 was defined
as a change of at least 4 units of insulin or a change of more
than 25% of other glucose-lowering medications.
Self-reported Behavioral Measures
Four domains of behavioral factors were used, including
intention, attitude, self-efficacy, and social norm toward en-
gagement in exercise (minimally 5 d/wk for 30 minutes of
MVPA), which is consistent with behavioral literature.15,37
These domains were measured with a 17-item questionnaire
that was based on the items of Boudreau and Godin.38 Par-
ticipants could indicate their extent of agreement on a
5-point Likert scale. For example, with social norm, partici-
pants could respond to the statement, “The most important
persons in my immediate area advise me to increase my
physical activity.” Answers could range from strongly dis-
agree (a score of 1) to strongly agree (a score of 5). Per do-
main (eg, for attitude, self-efficacy, and social norm), all
scores were added and subsequently divided by the number
of items. To determine the internal consistency of the differ-
ent items, Cronbach's α was calculated for attitude (seven
items), self-efficacy (six items), and social norm (three items).
After completion of the program intervention, partici-
pants were contacted by a member of the research team to
inquire about the perceived usefulness of the activity tracker
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and the eHealth program, as well as the impact of the pro-
gram on their physical activity and perceived health.
Statistical Analyses
A sample size computation with an expected mean HbA1c
of 7.5% ± 0.34% (59 ± 4 mmol/mol) at baseline indicated
the need for the inclusion of a minimum of 28 participants
per group in order to demonstrate a minimal relevant reduc-
tion of 0.27% (3 mmol/mol) with a statistical power of 80%
and a significance level of 5%.
Analysis occurred for all of the participants (intention-to-
treat analysis) using a repeated-measures analysis of variance,
with self-reported physical activity, HbA1c, AGEs, weight,
BMI, and waist-hip ratio as the dependent variables. Two
time intervals were included, T0 (week 0) and T1 (week 12),
to investigate for statistical differences between the interven-
tion and control groups over time. Age, sex, extra medication
at T0, perceived health at T0, intention to increase physical
activity at T0, attitude, self-efficacy, and social norm were
included as covariates.
Within the intervention group, a mixed models analysis
was used to analyze the change of physical activity over time,
measured as average steps per day from week 0 (baseline)
until week 12. The advantage of mixed models is that this
method can handle missing data; for example, a participant
with a missing week of average steps per day data would still
be included in the analysis. The intervention group was cat-
egorized into responders (eg, increasing a minimum of 1000
steps/d compared to baseline) and nonresponders (increas-
ing with <1000 steps/d) to further examine the effect on
HbA1c and other outcome measures.7–9 The average steps
per day were calculated by dividing the total steps of the spe-
cific week by the number of days the participant had mea-
sured steps with the activity tracker. It was determined that
it was necessary for any given participant to have at least
4 days of valid measurement per week in order to make a re-
liable calculation. It was decided that at least 500 steps had
to be measured during a day for it to be included in the anal-
ysis, since 500 steps represents 10% of 5000 steps, which is the
established cutoff point for sedentary behavior.39 It was rea-
soned that, when an individual had even 90% fewer steps than
the cutoff point of sedentary behavior, the activity tracker was
probably either not worn or not worn for the complete day.
RESULTS
Inclusion
Study participants were recruited between April 2015 and
July 2016. A total of 465 patients were screened, of whom 105
were eligible for inclusion. From these, 72 adults (47.2% female)
were randomly assigned to the intervention or control group
(Figure 1). During the study period, two participants from
the control group and one participant from the intervention
group dropped out. Three intervention participants were
unavailable for the follow-up primary outcome measure-
ment at T1. Therefore, 66 participants were included
in the analysis for the primary outcome (Figure 1). The
baseline characteristics of the participants are depicted
in Table 1. At baseline, the mean age was 56 ± 11 years,
mean diabetes duration was 15.3 ± 6.7 years, mean
HbA1c was 8.6% ± 1.0% (70.0 ± 11.3 mmol/mol), and
mean BMI was 32.9 ± 5 kg/m2. The participants were
primarily white (98.6%). No significant differences existed
between the intervention group and the control group at
T0. Ten participants (six in the intervention group and four
in the control group) received extra antihyperglycemic med-
ication at baseline (Table 2).
Adherence
Adherence to the intervention program was defined as hav-
ing worn the Fitbit on more than 75% of intervention days
and having read more than 50% of program content. The
latter was verified digitally and with the telephonic evalua-
tion. In this way, 82.5% of the intervention participants were
defined as being adherent.
Physical Activity
The intervention groupdemonstrated an increase of 1.5±3d/wk
of self-reported engagement in a minimum of 30 minutes of
MVPA, while the control group showed no increase (0.0 ± 1.8;
F=4.164, P= .047; Figure 2A).Within the intervention group,
physical activity data from the activity tracker were available for
36 of 40 participants (due to one dropout, one nonadherence
to the intervention procedure, and two participants experienc-
ing technical problems while pairing their activity trackers with
the eHealth program). The activity tracker disclosed a mean
of 5975± 2982 steps/d at the baseline week that significantly
increased during all of the intervention weeks (P < .010,
mixed models analysis; Table 3). Figure 2B illustrates the
average steps per day of the participants during all of the
intervention weeks. On average, participants increased
activity, with 1255 ± 1500 steps/d during the intervention
period. The control group participants, who received activity
trackers after finishing the control period at T1, averaged
6113 ± 2478 steps/d during their baseline week. This was
approximately the same as the baseline average steps per
day of the intervention group (mean difference, 138 steps/d;
P = .859).
Glycemic Control
There was no significant difference inHbA1c change between
the intervention group and the control group (F = 1.634,
P = .206). The intervention group showed a nonsignificant
mean decrease of −0.28% ± 1.03% (−3.1 ± 11.3 mmol/mol),
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and the control group showed no decrease (0.0% ± 0.69%,
−0.03 ± 7.5 mmol/mol) (Table 1).
Secondary Health Outcome Measures
No significant differences on the health-related outcomes
(AGEs, weight/BMI, and hip-waist ratio) were found be-
tween the intervention and control groups (P > .05) except
for the subjective health score (P = .02). No differences
existed in the change in medication prescription at T1,
with eight intervention group participants and six control
group participants receiving extra medication at T1. One
intervention group participant decreased medication at T1
(Table 2). All of the results on the health outcome measures
are presented in Table 1.
Subgroup Analyses and Covariates
More than half of the participants (56%) were defined as
“responders” (activity increased by at least 1000 steps/d
compared to baseline). When “being a responder” was in-
cluded in a subanalysis of intervention participants, a sig-
nificant interaction effect was found for being a responder
and HbA1c over time: −0.69% ± 1.18% (−7.6 ± 12.9 mmol/
mol) for responders and 0.22% ± 0.47% (2.4 ± 5.3 mmol/
mol) for nonresponders (F = 8.430, P = .007). No significant
results were associated with being a responder for other
health outcome measures (Table 4).
Cronbach's α for the different domains of the behavioral
questionnaire was .845, .860, and .683 for attitude, self-efficacy,
and social norm, respectively.
Table 1. Baseline Characteristics and Differences in Changes of Health Outcome Measures Between the
Intervention and Control Groups
ITT
Intervention Group (N = 40) Control Group (N = 32)
F b P bBaselinea D Baselinea D
Age, y 56.8 ± 11.4 NA 55.8 ± 11.4 NA NA NA
Diabetes duration, y 15.5 ± 7.7 NA 14.9 ± 5.3 NA NA NA
Medication use, %
Oral medication 77.5 NA 65.6 NA NA NA
GLP-1 therapy 25 21.9
Insulin 55 53.1
Insulin (based on users), units 62.9 ± 41.8 4.7 ± 15.2 76.4 ± 54.8 5.0 ± 10.3 NA NA
HbA1c, % 8.5 ± 0.87 −0.28 ± 1.03 8.6 ± 1.22 −0.0 ± 0.69 1.634 .206
HbA1c, mmol/mol 69.9 ± 9.5 −3.1 ± 11.3 70.2 ± 13.3 −0.03 ± 7.5 1.634 .206
AGEs, SF 2.46 ± 0.57 0.14 ± 0.34 2.60 ± 0.4 0.05 ± 0.35 0.661 .421
Weight, kg 102.2 ± 19.3 −0.1 ± 3.2 99.8 ± 16.3 0.5 ± 2.5 0.602 .441
BMI, kg/m2 33.2 ± 5.3 −0.02 ± 1.1 32.6 ± 4.5 0.17 ± 0.8 0.550 .462
Waist circumference, cm 112.1 ± 11.6 0.05 ± 3.4 116.4 ± 13.2 0.17 ± 5.2 0.011 .918
Hip circumference, cm 115.3 ± 8.9 0.0 ± 3.2 114.6 ± 11.5 −0.4 ± 4.1 0.140 .709
Waist-hip ratio, cm/cm 0.96 ± 0.17 0.03 ± 0.03 1.00 ± 0.17 0.04 ± 0.04 0.008 .928
Self-perceived health, points 5.7 ± 2 1.1 ± 2.3 5.6 ± 1.8 −0.3 ± 1.4 5.874 .020c
Abbreviations: NA, not applicable; SF, skin fluorescence; D, change between T0 and T1.
aAll variables were checked for normality, and influence of nonnormality was checked with Cook's distance.
bRepeated-measures analysis of variance for differences in change over time between the intervention and control groups.
cP < .05.
Table 2. Medication Use at Baseline and T1
Extra Medication at T0
(N = 10)a
Intervention
Group, n
Control
Group, n
Started with metformin 1 0
Started with SUs 0 0
Started with acarbose 0 0
Started with DPP-4 0 0
Started with GLP-1 0 0
Started with insulin 1 4
Increased insulin > 4 units 3 0
Started with more than one
type of medication
1 0
Change in Medication
at T1
Intervention
Group (N = 40), n
Control Group
(N = 32), n
No change in medication 32 26
Increased insulin > 4 units 4 6
Decreased insulin > 4 units 1 0
Increased dosage of other
medication
3 0
Decreased dosage of other
medication
0 0
aSix participants in the intervention group and four participants in the
control group received extra medication at baseline.
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Social normwas a significant covariate when added to the
main analysis (F= 7.475, P= .009). Age, sex, BMI, intention
to increase physical activity, attitude, and self-efficacy showed
no significant effects on HbA1c change. Also, extra medi-
cation at T0 had no significant main effect on HbA1c
(F = 3.102, P = .088). Within the intervention group, re-
sponders had a significantly higher social norm score at
baseline (P = .020) compared to nonresponders.
Patient Evaluations
Ninety percent of the intervention participants perceived the
activity tracker as being useful or very useful. A lower per-
centage (46%) qualified the eHealth program as being useful
or very useful, 28% as neutral, and 24% as not useful. Al-
most three-quarters of participants (74%) indicated that they
had increased physical activity behavior due to the interven-
tion program; 41% of the participants indicated that they in-
creased their activity levels a lot (daily changes), and 33%
indicated amoderate change (weekly changes). Slightly more
than half of the participants (51%) indicated that they felt
more fit or healthier since their participation in the program,
26% were uncertain, and 20% indicated that they did not
feel more fit or healthy.
Suggestions included improving the ease of use of the
eHealth program, providing an activity tracker with a Dutch
mobile application instead of English, and including content
(ie, video instruction on building physical strength) that is
more tailored to individual needs.
DISCUSSION
The goal of this study was to examine the effects of an online
self-tracking program on physical activity, glycemic control,
and other health outcome measures in people with type
2 diabetes. Physical activity significantly increased in the
intervention group and, from a certain level of increase (≥1000
steps/d), a clinically relevant decrease ofHbA1cwas determined.
Overall, for responders and nonresponders, no effects were
found on HbA1c or the other health outcome measures ex-
cept on the subjective health score. Changes in medication
at baseline did not affect the results.
To explain the lack of an overall effect on HbA1c, a more
thorough analysis was conducted on the activity tracker data
measured within the intervention group. The average steps
per day increased compared to the individual baselines
of the intervention group participants, with 1255 ± 1500
steps/d. Therefore, 39% of the participants complied with
the guideline of taking 7500 steps/d or more during the
Table 3. Change in Physical Activity (Average Steps per
Day) Over Time
Week Estimate (SE)a
Confidence Interval
PLower Upper
1 1284 (372) 552 2016 .001b
2 1172 (371) 442 1902 .002b
3 1536 (378) 793 2280 .000b
4 1351 (378) 607 2095 .000b
5 1399 (375) 660 2137 .005b
6 1116 (372) 385 1847 .003b
7 1063 (375) 326 1800 .005b
8 1384 (378) 641 2127 .000b
9 1031 (372) 301 1771 .006b
10 959 (372) 227 1690 .010b
11 1435 (375) 697 2173 .000b
12 1135 (369) 409 1860 .002b
All intervention weeks are compared with the baseline week (N = 36).
aLinear mixed models. The estimates from weeks 1 to 12 indicate the
estimated changes compared with baseline.
bP < .010.
FIGURE2. Change in physical activity from T0 to T1 in both groups (A) and change in steps per day from baseline till week 12within the
intervention group (B).
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intervention, and 61% did not. Substantial variability was
present in the increase of steps per day among the partic-
ipants, from −1355 to 5049 steps/d. This variability was
supported by the evaluation results; that is, 74% of the in-
tervention participants indicated having increased their phys-
ical activity (41% daily and 33% weekly activity), while 26%
had not. This interindividual variability may well explain the
absence of an overall significant decline in HbA1c in the in-
tervention group. Indeed, subgroup analysis showed that re-
sponders had a significant and clinically relevant decline in
HbA1c (−0.69% vs 0.22%, P = .007). Thus, for the complete
intervention group, the increase in physical activity was prob-
ably not enough to improve HbA1c. However, the combined
improvement of physical activity and HbA1c in responders
with advanced type 2 diabetes is clinically relevant and prom-
ising for the future. The prediction of responsiveness might be
a target of further research. Compared to the literature, the
increase in steps per day was lower than the standardized
mean difference of 1822 steps/d found in the meta-analysis
byQiu et al.40 This may be explained by the additional sup-
port, such as counseling or telephonic support, that was
provided in the studies reviewed by Qiu et al. In a recent
comparable, but larger, study by Dasgupta et al,41 physical
activity was increased by 1190 steps/d (95% confidence in-
terval, 550-1840) and HbA1c was decreased by 0.38%
compared to the control group. This is consistent with the
results found in our study.
The secondary health outcomes showed no significant
changes, even in the comparison of responders to nonre-
sponders. Advanced glycation end products are complex
linkage products measured in the tissue, and because the
accumulation of AGEs also depends on other factors
such as smoking behavior and intake of certain foods,34
it is likely that more long-term lifestyle changes are nec-
essary to achieve significant results on AGEs. Also, for
body weight and waist-hip ratio, no effects were found.
As an increase of at least 2000 steps/d is needed to achieve
relevant effects on weight and body composition,8,42 the lack
of findings on these measures is probably explained by the
smaller increase in the number of steps per day found in
this study.
Interestingly, social norm scores were a significant con-
founder for the HbA1c results, and responders had a higher
social norm score at baseline compared with nonresponders.
This result emphasizes the importance of taking into account
the social support of a patient with type 2 diabetes. In accor-
dance with this, the use of theory-based BCTs within self-
monitoring devices or lifestyle interventions is receiving
increasing attention within physical activity research. Several
studies pointed out the importance of providing information,
goal setting, action planning, self-monitoring, barrier identi-
fication, personalized feedback, and rewards.17,25,43 These
BCTs were present in our study; however, other important
BCTs, such as facilitating social support, changing environ-
mental factors, and using follow-up prompts, were lacking
in our intervention at a structural basis.43–46 In addition,
the BCT “action planning” was incorporated within the in-
formational documents but not structurally tailored for indi-
vidual participants. Since these BCTs are associated with
improved intervention outcomes in people with diabetes,
the lack of an overall effect may well be explained by insuffi-
cient structural implementation of these BCTs in our
study.45,46 This should be improved in future studies; for in-
stance, social support may be enhanced by the creation of a
system in which patients with diabetes are connected to each
other, perhaps for activities such as walking groups. Next to
the inclusion of additional evidence-based BCTs, effects of
future programs may also be enhanced by improving the
ease of use of digital techniques, incorporating additional
advances to use personal generated health data in a mean-
ingful way,20 and providing technical support from a per-
son other than the nurse. This will enhance the role of the
nurse for providing personal lifestyle support.20,29 Future
programs should incorporate a systematic approach to
Table 4. Results on Health Outcome Measures for Responders Versus Nonresponders Within the Intervention
Group (N = 36)
Responders (N = 20) Nonresponders (N = 16) F a P a
HbA1c, % −0.69 ± 1.18 0.22 ± 0.47 8.430 .007b
HbA1c, mmol/mol −7.6 ± 12.9 2.4 ± 5.3 8.430 .007b
AGEs, SF 0.06 ± 0.33 0.26 ± 0.32 1.816 .192
Weight, kg −0.3 ± 3.6 0.3 ± 2.7 0.388 .538
BMI, kg/m2 −0.08 ± 1.3 0.06 ± 0.9 0.416 .524
Waist circumference, cm −0.8 ± 3.7 1.4 ± 3.9 0.563 .459
Hip circumference, cm −0.3 ± 2.8 −0.4 ± 3.8 0.062 .805
Waist-hip ratio, cm/cm −0.08 ± 3.7 1.4 ± 3.9 0.796 .380
aRepeated-measures analysis of variance for differences in change over time between responders and nonresponders within the intervention group.
bP < .01.
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include all of these factors, including an analysis for appro-
priate intervention strategies.18
Our study has a number of strengths and limitations. The
first limitation is the relatively short-term follow-up period of
3 months, which was selected to afford the control group the
opportunity to engage in the program after finishing the
control period. This was intended to prevent an increased
withdrawal rate in the control group. However, a longer
duration may have been beneficial for incorporating lifestyle
habits and for a longer-term comparison with the control
group. Second, this study had a relatively small sample size.
Although we met the minimum number of participants
necessary from our sample size calculation, a larger group
would have strengthened the results. Third, this studymissed
an objective physical activity instrument for both groups. Be-
cause the Fitbit was an important component of the inter-
vention, the control group did not receive a Fitbit. However,
from the baseline step measurements that the control
group made after finishing their control period, it appeared
that they walked the same average steps per day compared
with the baseline steps per day of the intervention group.
This reinforces our finding that the intervention group in-
creased their average steps per day. A strength was that the
study was conducted in a general hospital setting, embedded
in the usual nursing care for patients with type 2 diabetes.
This real-life setting simplifies an extrapolation of the data
to the general population with type 2 diabetes. Also, as de-
termined from the evaluations, most participants were satis-
fied with the self-tracking program; 90% indicated that the
activity tracker was useful or very useful for them. This indi-
cates that patients with type 2 diabetes are willing to engage
in lifestyle programs based on self-tracking.
CONCLUSIONS
In our study, self-tracking of physical activity did improve phys-
ical activity in patients with advanced type 2 diabetes. The in-
tervention did not improve glycemic control overall, due to a
large interindividual variability in responsiveness to the inter-
vention. However, it did relevantly improve glycemic control
in 56% of the participants who increased their physical activity
with a minimum of 1000 steps/d. To improve the effectiveness
of online self-tracking programs on health outcomes, more de-
velopment in the ease of use of eHealth technology, integration
of BCTs, and tailoring of intervention programs is required, for
example, based on presence of social support.
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